Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2022	Oct. 29, 2021	Oct. 28, 2022	Oct. 29, 2021
Income Statement [Abstract]
Net sales	$ 7,585,000,000	$ 7,847,000,000	$ 14,955,000,000	$ 15,835,000,000
Costs and expenses:
Cost of products sold, excluding amortization of intangible assets	2,535,000,000	2,497,000,000	5,051,000,000	5,095,000,000
Research and development expense	676,000,000	676,000,000	1,368,000,000	1,426,000,000
Selling, general, and administrative expense	2,617,000,000	2,615,000,000	5,184,000,000	5,163,000,000
Amortization of intangible assets	421,000,000	431,000,000	844,000,000	866,000,000
Restructuring charges, net	30,000,000	10,000,000	44,000,000	21,000,000
Certain litigation charges, net	0	34,000,000	0	60,000,000
Other operating (income) expense, net	(97,000,000)	21,000,000	(62,000,000)	781,000,000
Operating profit	1,404,000,000	1,563,000,000	2,528,000,000	2,422,000,000
Other non-operating income, net	(109,000,000)	(66,000,000)	(192,000,000)	(177,000,000)
Interest expense	118,000,000	136,000,000	282,000,000	273,000,000
Income before income taxes	1,395,000,000	1,493,000,000	2,438,000,000	2,326,000,000
Income tax provision	959,000,000	176,000,000	1,072,000,000	240,000,000
Net income	435,000,000	1,317,000,000	1,367,000,000	2,086,000,000
Net income attributable to noncontrolling interests	(8,000,000)	(6,000,000)	(10,000,000)	(12,000,000)
Net income attributable to Medtronic	$ 427,000,000	$ 1,311,000,000	$ 1,356,000,000	$ 2,074,000,000
Basic earnings per share (usd per share)	$ 0.32	$ 0.97	$ 1.02	$ 1.54
Diluted earnings per share (usd per share)	$ 0.32	$ 0.97	$ 1.02	$ 1.53
Basic weighted average shares outstanding (shares)	1,329.4	1,345.1	1,329.4	1,344.8
Diluted weighted average shares outstanding (shares)	1,332.0	1,355.3	1,333.3	1,355.9